Sanibel Captiva Trust Company’s PTC Therapeutics PTCT Stock Holding History

Sanibel Captiva Trust Company’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$547K	Hold	6,700	–	–	0.01%	318
2026 Q1	$456K	Hold	6,700	–	–	0.01%	320
2025 Q4	$509K	Hold	6,700	–	–	0.01%	297
2025 Q3	$411K	Hold	6,700	–	–	0.01%	321
2025 Q2	$327K	Hold	6,700	–	–	0.01%	338
2025 Q1	$341K	Hold	6,700	–	–	0.01%	318
2024 Q4	$302K	Hold	6,700	–	–	0.01%	334
2024 Q3	$249K	Hold	6,700	–	–	0.01%	352
2024 Q2	$205K	Buy	+6,700	New	+$217K	0.01%	353

Other funds holding PTCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Sanibel Captiva Trust Company's PTCT Position: Q2 2026 in Review

Sanibel Captiva Trust Company held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 6,700 shares worth $547K. The position accounts for 0.01% of the portfolio, ranked #318.

Sanibel Captiva Trust Company first reported a position in PTCT in Q2 2024 and has held it in 9 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

Sanibel Captiva Trust Company held 6,700 shares of PTC Therapeutics worth $547K as of Q2 2026.
Sanibel Captiva Trust Company left its PTC Therapeutics share count unchanged in Q2 2026.
PTC Therapeutics made up 0.01% of Sanibel Captiva Trust Company's portfolio in Q2 2026, its #318 holding.
Sanibel Captiva Trust Company first reported a position in PTC Therapeutics in Q2 2024 and has held it in 9 quarters since.
382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Sanibel Captiva Trust Company's 13F filing for Q2 2026, filed 27 Jul 2026.